Shots: The approval is based on GEMINI 1 & 2 studies assessing dual drug regimen (dolutegravir 50 mg/lamivudine 300 mg) vs dolutegravir + two NRTIs [tenofovir disoproxil fumarate/emtricitabine (TDF/FTC)] in […]readmore
Tags : dolutegravir/lamivudine
Regulatory
ViiV Healthcare’s Dovato (dolutegravir/lamivudine) Receives FDA’s Approval to Treat HIV-1
Shots: The approval is based on P-III study GEMINI 1 (204861) and GEMINI 2 (205543) study results assessing dolutegravir and lamivudine vs DTG + TDF/FTC in 1400 patients with HIV-1 […]readmore